BRCA2A Antibody

Shipped with Ice Packs
In Stock

Description

BRCA2 Protein Overview

The BRCA2 protein (384 kDa) is encoded by the BRCA2 gene located on chromosome 13q12.3. Key functions include:

  • DNA Repair: Facilitates homologous recombination (HR) by recruiting RAD51 to single-stranded DNA (ssDNA), enabling accurate repair of double-strand breaks (DSBs) .

  • Tumor Suppression: Loss-of-function mutations increase risks for breast, ovarian, pancreatic, and prostate cancers .

  • Cytokinesis Regulation: May assist in cell division processes, though this role is less characterized .

Key BRCA2 Antibodies and Their Applications

Below is a comparative analysis of widely used BRCA2 antibodies, validated across diverse experimental systems:

Antibody NameHost/IsotypeApplicationsTarget RegionKey Findings
BRCA2 (D-8)Mouse IgG1WB, IP, IF, ELISAFull-length BRCA2Detects BRCA2 in human cells; used to study BRCA2-RAD51 interactions .
Human BRCA2 (MAB2476)Mouse IgG1WB, IHC, Flow CytometryMet1-Thr200 (N-terminal)Validated in pancreatic (Capan-1) and breast cancer tissues .
Anti-BRCA2 (ab9143)Rabbit IgGWB, IP, IFRAD51-binding BRC motifsStabilizes RAD51-ssDNA filaments by blocking ATP hydrolysis .
BRCA2 (29450-1-AP)Rabbit IgGWB, ELISAMultiple epitopesDetects endogenous BRCA2 in HeLa, MCF-7, and HepG2 cells .

DNA Repair Mechanisms

  • BRCA2 deficiency impairs HR, leading to error-prone repair via nonhomologous end joining (NHEJ) .

  • Key Evidence: BRCA2 reconstitution in Capan-1 cells increased HR efficiency by 10-fold, restoring RAD51-mediated DSB repair .

Therapeutic Implications

  • PARP Inhibitors: BRCA2-deficient cells show hypersensitivity to PARP inhibitors (e.g., olaparib) due to synthetic lethality .

  • Immunotherapy: BRCA2-deficient tumors exhibit enhanced response to immune checkpoint blockade (ICB) compared to BRCA1-deficient tumors, attributed to elevated immune infiltration .

Experimental Models

  • 5C6 Antibody Study: The lupus autoantibody 5C6 induced DNA damage (γH2AX foci) selectively in BRCA2-deficient DLD1 cells, reducing proliferation by 41% .

  • MANO-B Assay: High-throughput screening of 244 BRCA2 variants identified pathogenic mutations with 95% sensitivity/specificity using PARP inhibitor sensitivity as a readout .

Technical Considerations

  • Western Blot: BRCA2 migrates at ~380 kDa; reducing conditions are critical to prevent aggregation .

  • IHC Optimization: Heat-induced epitope retrieval (HIER) with citrate buffer improves staining in FFPE tissues .

Future Directions

  • Biomarker Development: Efforts to quantify homologous recombination deficiency (HRD) scores may expand PARP inhibitor use beyond BRCA-mutant cancers .

  • Structural Insights: Cryo-EM studies reveal BRCA2 dimers coordinate RAD51 filaments, informing drug design .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
BRCA2A antibody; BRCA5(IV) antibody; At4g00020/At4g00010 antibody; F6N15.14/F6N15.15Protein BREAST CANCER SUSCEPTIBILITY 2 homolog A antibody; AtBRCA2A antibody
Target Names
BRCA2A
Uniprot No.

Target Background

Function
This antibody targets BRCA2A, a protein involved in double-strand break repair and homologous recombination. BRCA2A mediates DNA repair by facilitating the action of RAD51 and DMC1. It plays a critical role in both somatic and meiotic homologous recombination, being essential for the formation of RAD51 and DMC1 foci during male meiotic prophase I homologous recombination.
Gene References Into Functions
The following studies highlight the function of BRCA2A:
  1. AtBRCA2 is crucial for proper meiotic synapsis and facilitates the recruitment of AtRAD51 and AtDMC1. (PMID: 22077663)
  2. Evidence indicates that the BRCA2-RAD51 complex, known for its role in homologous recombination (HR), also directly participates in transcriptional regulation during plant immune responses. (PMID: 21149701)
  3. Inefficient DNA repair in the *atbrca2a-/atbrca2b* double mutant disrupts the cell cycle in apical meristems. (PMID: 19457980)
  4. Brca2 plays an essential role in Arabidopsis meiosis. (PMID: 15014444)
Database Links

KEGG: ath:AT4G00020

STRING: 3702.AT4G00020.2

UniGene: At.33529

Tissue Specificity
Expressed in flower buds.

Q&A

Experimental Design for BRCA2 Antibody Validation

Question: What methods should be used to validate the specificity and sensitivity of BRCA2 antibodies in experimental settings?

Answer: Validation of BRCA2 antibodies involves several key methods:

  • Western Blot (WB): Use WB to assess antibody specificity by detecting BRCA2 protein in cell lysates.

  • Immunohistochemistry (IHC): Perform IHC on tissue samples to evaluate antibody performance in fixed tissues.

  • Immunoprecipitation (IP) and Mass Spectrometry (MS): Conduct IP-MS to confirm antibody specificity by identifying co-precipitated proteins.

  • Chromatin Immunoprecipitation (ChIP): Use ChIP to study BRCA2's role in chromatin remodeling and DNA repair.

Data Contradiction Analysis in BRCA2 Research

Question: How can researchers address data inconsistencies when using different BRCA2 antibodies across various studies?

Answer: Addressing data inconsistencies involves:

  • Cross-validation: Use multiple antibodies across different experimental platforms to confirm findings.

  • Literature Review: Compare results from similar studies to identify patterns or discrepancies.

  • Methodological Comparison: Analyze differences in experimental conditions, such as cell lines or tissue types, that might contribute to inconsistencies.

Advanced Research Questions: BRCA2 Function in DNA Repair

Question: What role does BRCA2 play in homologous recombination, and how can this be studied using BRCA2 antibodies?

Answer: BRCA2 is crucial for homologous recombination (HR), a process essential for DNA repair. To study this:

  • Immunofluorescence (IF): Use IF to visualize BRCA2 localization at DNA damage sites.

  • Cellular Assays: Perform assays that measure HR efficiency, such as DR-GFP or SSA assays, in cells with manipulated BRCA2 expression.

Methodological Considerations for BRCA2 Antibody Selection

Question: What criteria should researchers use when selecting a BRCA2 antibody for their studies?

Answer: When selecting a BRCA2 antibody, consider:

  • Specificity: Ensure the antibody specifically targets BRCA2 without cross-reacting with other proteins.

  • Sensitivity: Choose an antibody that can detect BRCA2 in the desired experimental conditions.

  • Application Suitability: Select antibodies validated for the intended application (e.g., WB, IHC, IF).

Data Interpretation Challenges in BRCA2 Research

Question: How can researchers interpret complex data from BRCA2 antibody experiments, especially when dealing with conflicting results?

Answer: Interpreting complex data involves:

  • Statistical Analysis: Use appropriate statistical methods to analyze data and identify significant trends.

  • Control Experiments: Include robust controls to validate experimental conditions and antibody performance.

  • Literature Contextualization: Place findings within the broader context of existing BRCA2 research to understand potential implications.

Advanced Techniques for BRCA2 Antibody-Based Research

Question: What advanced techniques can be employed to further elucidate BRCA2's role in cancer using BRCA2 antibodies?

Answer: Advanced techniques include:

  • Single-Molecule Localization Microscopy (SMLM): Use SMLM to study BRCA2's spatial organization at the nanoscale.

  • Proximity Ligation Assay (PLA): Perform PLA to detect protein-protein interactions involving BRCA2.

  • CRISPR-Cas9 Gene Editing: Use CRISPR-Cas9 to manipulate BRCA2 expression and study its effects on cellular processes.

Example Data Table: BRCA2 Antibody Validation

Antibody IDApplicationSpecificitySensitivity
Ab216972WB, IHCHighModerate
Ab123456IF, ChIPModerateHigh

This table illustrates how different antibodies perform across various applications, helping researchers choose the most suitable antibody for their studies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.